写在文章前的声明：在本文之前的说明：本文中所列的投资信息，只是一个对基金资产净值进行排行的客观描述，并无主观倾向性，也不是投资建议，纯属 娱乐性质。 一顿操作猛如虎，基金净值已更新，谁是基金中的王者，谁又垫底，请看数据： | 基金简称 PK | | | 最新净信息 | | | --- | --- | --- | --- | --- | | 1 | 银河核心优 ... C | 0.9049 | 4.77% | 8 | | | 016981 | 2025-11-7 | | | | 2 | 银河核心优... A | 0.9144 | 4.77% | 8 | | | 011629 | 2025-11-7 | | | | 3 | 泰信发展主 ... 合 | 1.8150 | 4.67% | 8 | | | 290008 | 2025-11-7 | | | | 4 | 泰信现代服 ... 合 | 2.0630 | 4.30% | 8 | | | 290014 | 2025-11-7 | | | | 5 | 汇丰晋信时... A | 1.0203 | 3.87% | 7 | | | 014917 | 2025-11-7 | ...

Group 1 - Qin'an Co., Ltd. experienced a decline of 5.03% on October 16, with a stock price of 15.68 CNY per share and a trading volume of 161 million CNY, resulting in a total market capitalization of 6.88 billion CNY [1] - The company, established on September 5, 1995, and listed on May 17, 2017, specializes in the research, production, and sales of core components for automotive engines, including cylinder blocks, cylinder heads, and crankshafts [1] - The main business revenue composition includes: machining division 96.71%, casting division 58.96%, and others 2.34% [1] Group 2 - According to data, one fund from Fuyuan Fund holds a significant position in Qin'an Co., with Fuyuan Fuxin Mixed A (005164) holding 139,700 shares, accounting for 5.18% of the fund's net value, ranking as the sixth largest holding [2] - The fund has reported a floating loss of approximately 116,000 CNY today [2] - Fuyuan Fuxin Mixed A was established on March 16, 2018, with a current scale of 7.317 million CNY, and has achieved a year-to-date return of 12.98% [2]

9月18日，秦安股份跌5.03%，截至发稿，报15.48元/股，成交2.41亿元，换手率3.44%，总市值67.93亿 元。 资料显示，重庆秦安机电股份有限公司位于重庆市九龙坡区西彭工业园区森迪大道58号，成立日期1995 年9月5日，上市日期2017年5月17日，公司主营业务涉及从事汽车发动机核心零部件:气缸体、气缸盖、 曲轴等产品的研发、生产与销售。主营业务收入构成为：缸盖54.87%，缸体19.36%，变速器箱体及其 他13.34%，曲轴10.47%，其他(补充)1.95%。 富荣福锦混合A（005164）成立日期2018年3月16日，最新规模731.7万。今年以来收益27.78%，同类排 名3307/8172；近一年收益102.68%，同类排名504/7980；成立以来收益172.18%。 富荣福锦混合A（005164）基金经理为李延峥、毛运宏。 截至发稿，李延峥累计任职时间4年94天，现任基金资产总规模2.88亿元，任职期间最佳基金回报 85.13%， 任职期间最差基金回报-31.03%。 毛运宏累计任职时间113天，现任基金资产总规模4442.41万元，任职期间最佳基金回报33.07%， 任职 期 ...

2025年8月26日，西菱动力(300733.SZ)发布2025年半年度报告。截至2025年8月25日，共有12个机构投 资者披露持有西菱动力A股股份，合计持股量达2486.01万股，占西菱动力总股本的8.13%。其中，前十 大机构投资者包括中国银行股份有限公司-华夏行业景气混合型证券投资基金、前海人寿保险股份有限 公司-分红保险产品、华夏基金管理有限公司-社保基金四二二组合、平安银行股份有限公司-华夏远见成 长一年持有期混合型证券投资基金、前海人寿保险股份有限公司-分红保险产品华泰组合、中国工商银 行股份有限公司-易方达新兴成长灵活配置混合型证券投资基金、中国银行股份有限公司-华泰保兴吉年 丰混合型发起式证券投资基金、华泰保兴吉年利、长城核心优势混合A、富荣福锦混合A，前十大机构 投资者合计持股比例达8.06%。相较于上一季度，前十大机构持股比例合计上涨了2.94个百分点。 对于社保基金，本期较上一期持股增加的社保基金共1个，即华夏基金管理有限公司-社保基金四二二组 合，持股增加占比达0.15%。 公募基金方面，本期较上一期持股增加的公募基金共计1个，即华夏行业景气混合，持股增加占比小幅 上涨。本期较上一季 ...

Core Viewpoint - The article provides a ranking of open-end mutual funds based on their net asset value growth as of August 6, 2025, highlighting the top and bottom performers in the market [2][4][6]. Group 1: Top Performing Funds - The top 10 funds with the highest net value growth include: 1. Zhonghai Charm Yangtze River Delta Mixed Fund (3.1350) 2. Hengyue Smart Technology Mixed C Fund (1.1892) 3. Hengyue Smart Technology Mixed A Fund (1.1996) 4. Minsheng Jianyin Frontier Technology Mixed Fund (1.0201) 5. Tongtai Competitive Advantage Mixed A Fund (1.1032) 6. Tongtai Competitive Advantage Mixed C Fund (1.0802) 7. Furong Fuxin Mixed C Fund (2.1194) 8. Furong Fuxin Mixed A Fund (2.1560) 9. Hongyi Yuanfang Selected Mixed C Fund (1.1215) 10. Hongyi Yuanfang Selected Mixed A Fund (1.1231) [2][4]. Group 2: Bottom Performing Funds - The bottom 10 funds with the lowest net value growth include: 1. Guotai Innovation Medical Mixed Initiation C Fund (1.1799) 2. Guotai Innovation Medical Mixed Initiation A Fund (1.1901) 3. Wanjia Pharmaceutical Quantitative Stock Selection Mixed Initiation C Fund (1.2070) 4. Wanjia Pharmaceutical Quantitative Stock Selection Mixed Initiation A Fund (1.2165) 5. Morgan Stanley Youyue Anhe Mixed C Fund (0.6632) 6. Morgan Stanley Youyue Anhe Mixed A Fund (0.6727) 7. Hongde Medical Innovation Mixed Initiation A Fund (1.0426) 8. Hongde Medical Innovation Mixed Initiation C Fund (1.0274) 9. Guotai Growth Enterprise Board Medical Health ETF (1.2310) 10. Tianhong Medical Innovation A Fund (1.0690) [4][6]. Group 3: Market Overview - The Shanghai Composite Index showed a slight upward trend, with a trading volume of 1.75 trillion, and the number of advancing stocks was 3,357 compared to 1,817 declining stocks [6]. - Leading sectors included shipbuilding and general machinery, both rising over 3%, while the tourism sector experienced declines [6].

Core Viewpoint - In May 2025, over 70% of the 8,451 comparable mixed funds experienced net value increases, indicating a positive trend in the market [1] Fund Performance Summary - A total of 54 mixed funds achieved a monthly increase of over 10%, with Jinxin Value Selected Mixed A and C leading at 19.38% and 19.36% respectively [2] - Jinxin Value Selected Mixed A and C, established on September 1, 2017, reported year-to-date returns of 32.65% and 32.60%, and cumulative returns of 48.85% and 49.57% as of May 30, 2025 [2] - The top ten holdings of Jinxin Value Selected Mixed A and C focus on the pharmaceutical and biotechnology sectors, particularly in innovative industries [2] - Huabao Pharmaceutical and Biological Mixed A achieved a monthly increase of 11.49%, with a year-to-date return of 41.55% and a cumulative return of 381.22% since its inception [3] Fund Decline Summary - 15 mixed funds saw declines exceeding 10% in May, with Furong Fuxin Mixed C and A at the bottom with -12.39% and -12.38% respectively [4] - Furong Fuxin Mixed C and A focus on humanoid robotics, with their top holdings including Huachen Equipment and Qinchuan Machine Tool [4] Fund Manager Insights - The current fund manager for Jinxin Value Selected Mixed A and C is Zhao Haoran, who has a background in financial research and joined Jinxin Fund in August 2022 [2] - Huabao Pharmaceutical and Biological Mixed A is managed by Zhang Jintao, who has extensive experience in investment research across various financial institutions [3] - Furong Fuxin Mixed C and A are co-managed by Li Yanzheng and Mao Yunhong, both of whom have significant experience in research and fund management [4]